Abstract
This article hopes to summarize the fundamental attributes of enlisted preliminaries of 2019 novel (COVID-19), to the extent their spatial and transitory scatterings, kinds of plan and mediations, and patient characteristics among others. A sweeping inquiry of the enlisted COVID-19 preliminaries has been performed on stages including ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (WHO ICTRP), Chinese Clinical Trials Registry (CHiCTR), Australian Clinical Trials Registry, Britain's National Research Register (BNRR), Current Control Trials (CCT), and Glaxo Smith Kline Register. Starters enrolled at the underlying two months of the COVID-19 erupt are consolidated, without language restrictions. For every assessment, the enlistment information, study plan, and chief information are assembled and summarized.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
